Monte Rosa Therapeutics (GLUE) Revenue (2020 - 2026)
Monte Rosa Therapeutics (GLUE) reported Revenue of $8.97 million for Q2 2026, down 61.3% from $23.19 million a year earlier but up 113.0% from the prior quarter.
Powered by 
Analysis
Monte Rosa Therapeutics (GLUE) Revenue (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Monte Rosa Therapeutics' Revenue came in at $28.73 million, down 83.9% year-over-year; for FY2025, it was $123.67 million, up 63.5% from FY2024.
- By year, Revenue came in at $75.62 million in FY2024.
- Five-year quarterly Revenue spans a low of $1.06 million in Q1 2024 and a high of $84.93 million in Q1 2025.
- Year over year, Revenue has now declined in each of the last three quarters, with growth averaging 36.2% over the last five quarters.
- Per Business Quant data, the three quarters before Q2 2026 came in at $4.21 million (Q1 2026), $2.78 million (Q4 2025) and $12.77 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 25.31 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Monte Rosa Therapeutics | 1.14 Bn | 550.40 Mn | - | 8.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.97 Mn |
| Mar 31, 2026 | 4.21 Mn |
| Dec 31, 2025 | 2.78 Mn |
| Sep 30, 2025 | 12.77 Mn |
| Jun 30, 2025 | 23.19 Mn |
| Mar 31, 2025 | 84.93 Mn |
| Dec 31, 2024 | 60.65 Mn |
| Sep 30, 2024 | 9.22 Mn |
| Jun 30, 2024 | 4.70 Mn |
| Mar 31, 2024 | 1.06 Mn |
| Dec 31, 2022 | 1.99 Mn |
| Sep 30, 2022 | 997,000.00 |
| Jun 30, 2022 | 628,000.00 |
| Mar 31, 2022 | 149,000.00 |
| Dec 31, 2021 | 13,000.00 |
| Sep 30, 2021 | 13,000.00 |
| Jun 30, 2021 | 14,000.00 |
| Mar 31, 2021 | 6,000.00 |
| Dec 31, 2020 | 9,000.00 |
| Sep 30, 2020 | 2,000.00 |
API Access
Monte Rosa Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=GLUE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "GLUE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=GLUE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();